OCCUPATIONAL HEALTH FOR SHO 2.0
Medical surveillance management
The lectures try to provide all the reasons and rational of a medical surveillance program for chemical hazardous to health. It differentiates between the regulatory medical surveillance under the USECHH Regulations and the voluntary medical surveillance.
It provide the necessary understanding of critical information such as the concepts of Permissible Exposure Limits, action levels, CHRA, biological monitoring, and target organ monitoring.
It focuses on the decision making process of the CHRA assessment, chemical exposure monitoring data interpretation, biological monitoring result interpretation and the strategy recommended based on the DOSH Health surveillance guidelines.
It try to empower the Occupational Health Doctor, safety and Health officer, and managers with the necessary knowledge, to better manage the medical surveillance of chemicals hazardous to health at the workplace.
Medical surveillance program for chemical hazardous to health is regulated under the USECHH Regulations 27. The health surveillance guidelines by DOSH Malaysia provides the necessary understanding of the implementation of the program. Necessary and proper understanding of the subject is critical for proper management of the medical surveillance program.
To provide the necessary knowledge for the safety officers, occupational health Doctor, and managers to manage a successful medical surveillance programme and at the same time understand that the regulatory medical surveillance program is a high risk program that is conducted due to poor control of the chemical health hazards.
·Understand the Permissible Exposure Limits, action levels, biological monitoring, and target organ monitoring.
·Understand the CHRA decision making process and role of safety officers.
·Understand the medical surveillance program described in the health surveillance guidelines by DOSH Malaysia.
·Understand biological monitoring, its strengths, weakness and limitations.
·Understand target organs medical assessment as the basis of medical surveillance program.
·Understand that regulatory medical surveillance is a high risk program.
·Understand the concept of voluntary medical surveillance program.
Training topics and contents
- Permissible exposure limits and what it means
- CHRA and decision making process
- Chemical exposure monitoring issues and results interpretation
- DOSH’s health surveillance guidelines
- Understand the health surveillance guidelines based on few chemical examples
- Biological monitoring issues and results interpretation
- Health effect and organ assessment issues and interpretation
- Voluntary medical surveillance as proactive program to monitor chemical health risks.
- MUHAMMAD FAIZ BIN ZULKIFLI
- RAMEISH RAO A/L SUBARMANIYAN
- RAMAN A/L MUNIANDY
- Ramesh A/L M.Shanmugam
- SHUHAIRI BIN YAAKOB
- TAN YI NING
- Mohd Taufiq Bin Zahaba
- Mohd Faizal Bin Zulkipli
- Ahmad Zamzuri bin Mohd Nazar
- Abd Manan Abu Bakar
- Mohd Azizi Khairuddin
- ahmad azwad mat seman
- ELLI YANTI BINTI KHALID
- Irwan Sukma Sukarman
- Nik Azrim bin Nik Yaakub
- Mohd Firdaus Ma'as
- Saravanan A/L Lingeswaran
- MOHD TAKIYUDDIN BIN ABDULL RAHMAN
- Dr Norhayati abdul rauf
- Abdul Ghafar Bin Nordin
- MUHAMMAD SYAMIM BIN SUHAIMI
- Kalaivaanan Murugan
- Mohd hafiz bin mohd yusof
- MOHAMAD AZWAN BIN ABD AZIZ
- Maslina Binti Minhad
- NGU HAW LING
- NORWAHIDA YAAKUB
- Muthuckumar Arumugam
- Muhamad Zulhilmi bin Musa
- N M ANANDA MURTHY A/L K NARAYANA MOORTHY
- WAN ZAKUAN BIN WAN MOHD ZAIN
- Aaron Arthur Asai
- SIVABALAN A/L SANMUGUM
- MUHAMMAD HANIF BIN SULAIMAN
- koh kim chwan
- Syazzan Fared bin Idrus